It takes two to tango: Understanding the interactions between engineered nanomaterials and the immune system

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 95, Issue , 2015, Pages 3-12

  Farrera, Consol ^a   Fadeel, Bengt ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Bio corona; Danger signals; Inflammasome; Macrophages; Nanomaterials; Nanotoxicology

Indexed keywords

INFLAMMASOME; NANOMATERIAL; NANOPARTICLE;

ADAPTIVE IMMUNITY; ADSORPTION; ARTICLE; CELLS BY BODY ANATOMY; CHEMICAL INTERACTION; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOTOXICITY; INNATE IMMUNITY; NANOENGINEERING; NANOTOXICOLOGY; PATTERN RECOGNITION; SURFACE CHARGE; SURFACE PROPERTY; ANIMAL; COMPREHENSION; DRUG EFFECTS; IMMUNOLOGY; MACROPHAGE; PHAGOCYTE;

ADSORPTION; ANIMALS; COMPREHENSION; HUMANS; IMMUNE SYSTEM; MACROPHAGES; NANOSTRUCTURES; PHAGOCYTES;

EID: 84940730176     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2015.03.007     Document Type: Article

References (105)

1. H.F. Krug, and P. Wick Nanotoxicology: an interdisciplinary challenge Angew. Chem. Int. Ed. Engl. 50 2011 1260 1278
2. B. Fadeel, N. Feliu, C. Vogt, A.M. Abdelmonem, and W.J. Parak Bridge over troubled waters: understanding the synthetic and biological identities of engineered nanomaterials Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 5 2013 111 129
3. A. Nel, T. Xia, H. Meng, X. Wang, S. Lin, Z. Ji, and H. Zhang Nanomaterial toxicity testing in the 21st century: use of a predictive toxicological approach and high-throughput screening Acc. Chem. Res. 46 2013 607 621
4. S.J. Sturla, A.R. Boobis, R.E. FitzGerald, J. Hoeng, R.J. Kavlock, K. Schirmer, M. Whelan, M.F. Wilks, and M.C. Peitsch Systems toxicology: from basic research to risk assessment Chem. Res. Toxicol. 27 2014 314 329
5. A.A. Shvedova, V.E. Kagan, and B. Fadeel Close encounters of the small kind: adverse effects of man-made materials interfacing with the nano-cosmos of biological systems Annu. Rev. Pharmacol. Toxicol. 50 2010 63 88
6. N.J. Gay, M.F. Symmons, M. Gangloff, and C.E. Bryant Assembly and localization of Toll-like receptor signalling complexes Nat. Rev. Immunol. 14 2014 546 558
7. J.A. Hubbell, S.N. Thomas, and M.A. Swartz Materials engineering for immunomodulation Nature 462 2009 449 460
8. A.D. Maynard, D.B. Warheit, and M.A. Philbert The new toxicology of sophisticated materials: nanotoxicology and beyond Toxicol. Sci. 120 Suppl. 1 2011 S109 S129
9. G. Oberdörster Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology J. Intern. Med. 267 2010 89 105
10. H.F. Krug Nanosafety research-are we on the right track? Angew. Chem. Int. Ed. Engl. 53 2014 12304 12319
11. K. Donaldson, and C.A. Poland Nanotoxicity: challenging the myth of nano-specific toxicity Curr. Opin. Biotechnol. 24 2013 724 734
12. M.I. Setyawati, C.Y. Tay, S.L. Chia, S.L. Goh, W. Fang, M.J. Neo, H.C. Chong, S.M. Tan, S.C. Loo, K.W. Ng, J.P. Xie, C.N. Ong, N.S. Tan, and D.T. Leong Titanium dioxide nanomaterials cause endothelial cell leakiness by disrupting the homophilic interaction of VE-cadherin Nat. Commun. 4 2013 1673
13. M.P. Monopoli, C. Åberg, A. Salvati, and K.A. Dawson Biomolecular coronas provide the biological identity of nanosized materials Nat. Nanotechnol. 7 2012 779 786
14. H.S. Choi, Y. Ashitate, J.H. Lee, S.H. Kim, A. Matsui, N. Insin, M.G. Bawendi, M. Semmler-Behnke, J.V. Frangioni, and A. Tsuda Rapid translocation of nanoparticles from the lung airspaces to the body Nat. Biotechnol. 28 2010 1300 1303
15. Y. Geng, P. Dalhaimer, S. Cai, R. Tsai, M. Tewari, T. Minko, and D.E. Discher Shape effects of filaments versus spherical particles in flow and drug delivery Nat. Nanotechnol. 2 2007 249 255
16. W.K. Oh, S. Kim, M. Choi, C. Kim, Y.S. Jeong, B.R. Cho, J.S. Hahn, and J. Jang Cellular uptake, cytotoxicity, and innate immune response of silica-titania hollow nanoparticles based on size and surface functionality ACS Nano 4 2010 5301 5313
17. C.D. Walkey, and W.C. Chan Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment Chem. Soc. Rev. 41 2012 2780 2799
18. F. Wang, L. Yu, M.P. Monopoli, P. Sandin, E. Mahon, A. Salvati, and K.A. Dawson The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomes Nanomedicine 9 2013 1159 1168
19. K. Bhattacharya, L. Farcal, and B. Fadeel Shifting identities of metal oxide nanoparticles: focus on inflammation MRS Bull. 39 2014 970 975
20. M. Yang, K. Flavin, I. Kopf, G. Radics, C.H. Hearnden, G.J. McManus, B. Moran, A. Villalta-Cerdas, L.A. Echegoyen, S. Giordani, and E.C. Lavelle Functionalization of carbon nanoparticles modulates inflammatory cell recruitment and NLRP3 inflammasome activation Small 9 2013 4194 4206
21. R. Li, X. Wang, Z. Ji, B. Sun, H. Zhang, C.H. Chang, S. Lin, H. Meng, Y.P. Liao, M. Wang, Z. Li, A.A. Hwang, T.B. Song, R. Xu, Y. Yang, J.I. Zink, A.E. Nel, and T. Xia Surface charge and cellular processing of covalently functionalized multiwall carbon nanotubes determine pulmonary toxicity ACS Nano 7 2013 2352 2368
22. N. Gao, Q. Zhang, Q. Mu, Y. Bai, L. Li, H. Zhou, E.R. Butch, T.B. Powell, S.E. Snyder, G. Jiang, and B. Yan Steering carbon nanotubes to scavenger receptor recognition by nanotube surface chemistry modification partially alleviates NFκB activation and reduces its immunotoxicity ACS Nano 5 2011 4581 4591
23. Z.J. Deng, M. Liang, M. Monteiro, I. Toth, and R.F. Minchin Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation Nat. Nanotechnol. 6 2011 39 44
24. Y. Yan, K.T. Gause, M.M. Kamphuis, C.S. Ang, N.M. O'Brien-Simpson, J.C. Lenzo, E.C. Reynolds, E.C. Nice, and F. Caruso Differential roles of the protein corona in the cellular uptake of nanoporous polymer particles by monocyte and macrophage cell lines ACS Nano 7 2013 10960 10970
25. S. Tenzer, D. Docter, J. Kuharev, A. Musyanovych, V. Fetz, R. Hecht, F. Schlenk, D. Fischer, K. Kiouptsi, C. Reinhardt, K. Landfester, H. Schild, M. Maskos, S.K. Knauer, and R.H. Stauber Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology Nat. Nanotechnol. 8 2013 772 781
26. M.A. Dobrovolskaia, B.W. Neun, S. Man, X. Ye, M. Hansen, A.K. Patri, R.M. Crist, and S.E. McNeil Protein corona composition does not accurately predict hematocompatibility of colloidal gold nanoparticles Nanomedicine 10 2014 1453 1463
27. C. Ge, J. Du, L. Zhao, L. Wang, Y. Liu, D. Li, Y. Yang, R. Zhou, Y. Zhao, Z. Chai, and C. Chen Binding of blood proteins to carbon nanotubes reduces cytotoxicity Proc. Natl. Acad. Sci. U.S.A. 108 2011 16968 16973
28. D. Dutta, S.K. Sundaram, J.G. Teeguarden, B.J. Riley, L.S. Fifield, J.M. Jacobs, S.R. Addleman, G.A. Kaysen, B.M. Moudgil, and T.J. Weber Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials Toxicol. Sci. 100 2007 303 315
29. J. Shi, H.L. Karlsson, K. Johansson, V. Gogvadze, L. Xiao, J. Li, T. Burks, A. Garcia-Bennett, A. Uheida, M. Muhammed, S. Mathur, R. Morgenstern, V.E. Kagan, and B. Fadeel Microsomal glutathione transferase 1 protects against toxicity induced by silica nanoparticles but not by zinc oxide nanoparticles ACS Nano 6 2012 1925 1938
30. A. Lesniak, F. Fenaroli, M.P. Monopoli, C. Åberg, K.A. Dawson, and A. Salvati Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells ACS Nano 6 2012 5845 5857
31. C. Vogt, M. Pernemalm, P. Kohonen, S. Laurent, K. Hultenby, M. Vahter, J. Lehtiö, M. Toprak, B. Fadeel, Proteomics analysis reveals distinct corona compositions on magnetic nanoparticles with different surface coating: implications for interactions with primary human macrophages, PLoS One (2015) (Submitted for publication).
32. C.D. Walkey, J.B. Olsen, F. Song, R. Liu, H. Guo, W. Olsen, Y. Cohen, A. Emili, and W.C. Chan Protein corona fingerprinting predicts the cell association of gold nanoparticles ACS Nano 8 2014 2439 2455
33. K. Prapainop, D.P. Witter, and P. Wentworth A chemical approach for cell-specific targeting of nanomaterials: small-molecule-initiated misfolding of nanoparticle corona proteins J. Am. Chem. Soc. 134 2012 4100 4103
34. B. Pulendran, and R. Ahmed Immunological mechanisms of vaccination Nat. Immunol. 12 2011 509 517
35. C. Nathan Neutrophils and immunity: challenges and opportunities Nat. Rev. Immunol. 6 2006 173 182
36. D. Boraschi, L. Costantino, and P. Italiani Interaction of nanoparticles with immunocompetent cells: nanosafety considerations Nanomedicine (Lond.) 7 2012 121 131
37. S. Hussain, J.A. Vanoirbeek, and P.H. Hoet Interactions of nanomaterials with the immune system Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 4 2012 169 183
38. D.M. Underhill, and H.S. Goodridge Information processing during phagocytosis Nat. Rev. Immunol. 12 2012 492 502
39. C.A. Poland, R. Duffin, I. Kinloch, A. Maynard, W.A. Wallace, A. Seaton, V. Stone, S. Brown, W. Macnee, and K. Donaldson Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study Nat. Nanotechnol. 3 2008 423 428
40. A. Sica, and A. Mantovani Macrophage plasticity and polarization: in vivo veritas J. Clin. Invest. 122 2012 787 795
41. S.W. Jones, R.A. Roberts, G.R. Robbins, J.L. Perry, M.P. Kai, K. Chen, T. Bo, M.E. Napier, J.P. Ting, J.M. Desimone, and J.E. Bear Nanoparticle clearance is governed by Th1/Th2 immunity and strain background J. Clin. Invest. 123 2013 3061 3073
42. E. Witasp, A.A. Shvedova, V.E. Kagan, and B. Fadeel Single-walled carbon nanotubes impair human macrophage engulfment of apoptotic cell corpses Inhal. Toxicol. 21 Suppl. 1 2009 131 136
43. M. Lundborg, S.E. Dahlén, U. Johard, P. Gerde, C. Jarstrand, P. Camner, and L. Låstbom Aggregates of ultrafine particles impair phagocytosis of microorganisms by human alveolar macrophages Environ. Res. 100 2006 197 204
44. A.A. Shvedova, J.P. Fabisiak, E.R. Kisin, A.R. Murray, J.R. Roberts, Y.Y. Tyurina, J.M. Antonini, W.H. Feng, C. Kommineni, J. Reynolds, A. Barchowsky, V. Castranova, and V.E. Kagan Sequential exposure to carbon nanotubes and bacteria enhances pulmonary inflammation and infectivity Am. J. Respir. Cell Mol. Biol. 38 2008 579 590
45. V. Kodali, M.H. Littke, S.C. Tilton, J.G. Teeguarden, L. Shi, C.W. Frevert, W. Wang, J.G. Pounds, and B.D. Thrall Dysregulation of macrophage activation profiles by engineered nanoparticles ACS Nano 7 2013 6997 7010
46. G.P. Kotchey, Y. Zhao, V.E. Kagan, and A. Star Peroxidase-mediated biodegradation of carbon nanotubes in vitro and in vivo Adv. Drug Deliv. Rev. 65 2013 1921 1932
47. V.E. Kagan, N.V. Konduru, W. Feng, B.L. Allen, J. Conroy, Y. Volkov, I.I. Vlasova, N.A. Belikova, N. Yanamala, A. Kapralov, Y.Y. Tyurina, J. Shi, E.R. Kisin, A.R. Murray, J. Franks, D. Stolz, P. Gou, J. Klein-Seetharaman, B. Fadeel, A. Star, and A.A. Shvedova Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation Nat. Nanotechnol. 5 2010 354 359
48. C. Farrera, K. Bhattacharya, B. Lazzaretto, F.T. Andón, K. Hultenby, G.P. Kotchey, A. Star, and B. Fadeel Extracellular entrapment and degradation of single-walled carbon nanotubes Nanoscale 6 2014 6974 6983
49. F.T. Andón, A.A. Kapralov, N. Yanamala, W. Feng, A. Baygan, B.J. Chambers, K. Hultenby, F. Ye, M.S. Toprak, B.D. Brandner, A. Fornara, J. Klein-Seetharaman, G.P. Kotchey, A. Star, A.A. Shvedova, B. Fadeel, and V.E. Kagan Biodegradation of single-walled carbon nanotubes by eosinophil peroxidase Small 9 2013 2721 2729
50. V.E. Kagan, A.A. Kapralov, C.M. St. Croix, S.C. Watkins, E.R. Kisin, G.P. Kotchey, K. Balasubramanian, I.I. Vlasova, J. Yu, K. Kim, W. Seo, R.K. Mallampalli, A. Star, and A.A. Shvedova Lung macrophages "digest" carbon nanotubes using a superoxide/peroxynitrite oxidative pathway ACS Nano 8 2014 5610 5621
51. C.M. Girish, A. Sasidharan, G.S. Gowd, S. Nair, and M. Koyakutty Confocal Raman imaging study showing macrophage mediated biodegradation of graphene in vivo Adv. Healthc. Mater. 2 2013 1489 1500
52. M.E. Bianchi DAMPs, PAMPs and alarmins: all we need to know about danger J. Leukoc. Biol. 81 2007 1 5
53. T. Strowig, J. Henao-Mejia, E. Elinav, and R. Flavell Inflammasomes in health and disease Nature 481 2012 278 286
54. M.G. Netea, A. Simon, F. van de Veerdonk, B.J. Kullberg, J.W. Van der Meer, and L.A. Joosten IL-1β processing in host defense: beyond the inflammasomes PLoS Pathog. 26 2010 e1000661
55. C. Dostert, V. Pétrilli, R. Van Bruggen, C. Steele, B.T. Mossman, and J. Tschopp Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica Science 320 2008 674 677
56. A.S. Yazdi, G. Guarda, N. Riteau, S.K. Drexler, A. Tardivel, I. Couillin, and J. Tschopp Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1β Proc. Natl. Acad. Sci. U.S.A. 107 2010 19449 19454
57. O. Lunov, T. Syrovets, C. Loos, G.U. Nienhaus, V. Mailänder, K. Landfester, M. Rouis, and T. Simmet Amino-functionalized polystyrene nanoparticles activate the NLRP3 inflammasome in human macrophages ACS Nano 5 2011 9648 9657
58. J. Palomäki, E. Välimäki, J. Sund, M. Vippola, P.A. Clausen, K.A. Jensen, K. Savolainen, S. Matikainen, and H. Alenius Long, needle-like carbon nanotubes and asbestos activate the NLRP3 inflammasome through a similar mechanism ACS Nano 5 2011 6861 6870
59. A. Abderrazak, T. Syrovets, D. Couchie, K. El Hadri, B. Friguet, T. Simmet, and M. Rouis NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases Redox Biol. 4C 2015 296 307
60. S.C. Eisenbarth, O.R. Colegio, W. O'Connor, F.S. Sutterwala, and R.A. Flavell Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants Nature 453 2008 1122 1126
61. R. Li, Z. Ji, C.H. Chang, D.R. Dunphy, X. Cai, H. Meng, H. Zhang, B. Sun, X. Wang, J. Dong, S. Lin, M. Wang, Y.P. Liao, C.J. Brinker, A.E. Nel, and T. Xia Surface interactions with compartmentalized cellular phosphates explains rare earth oxide nanoparticle hazard and provides opportunities for safer design ACS Nano 8 2014 1771 1783
62. F.T. Andón, and B. Fadeel Programmed cell death: molecular mechanisms and implications for safety assessment of nanomaterials Acc. Chem. Res. 46 2013 733 742
63. C.S. Shi, K. Shenderov, N.N. Huang, J. Kabat, M. Abu-Asab, K.A. Fitzgerald, A. Sher, and J.H. Kehrl Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction Nat. Immunol. 13 2012 255 263
64. R. Li, Z. Ji, H. Qin, X. Kang, B. Sun, M. Wang, C.H. Chang, X. Wang, H. Zhang, H. Zou, A.E. Nel, and T. Xia Interference in autophagosome fusion by rare earth nanoparticles disrupts autophagic flux and regulation of an interleukin-1β producing inflammasome ACS Nano 8 2014 10280 10292
65. B. Sun, X. Wang, Z. Ji, M. Wang, Y.P. Liao, C.H. Chang, R. Li, H. Zhang, A.E. Nel, and T. Xia NADPH oxidase-dependent NLRP3 inflammasome activation and its important role in lung fibrosis by multiwalled carbon nanotubes Small 2015 (Epub ahead of print)
66. B. Sun, X. Wang, Z. Ji, R. Li, and T. Xia NLRP3 inflammasome activation induced by engineered nanomaterials Small 9 2013 1595 1607
67. F. Jessop, and A. Holian Extracellular HMGB1 regulates multi-walled carbon nanotube-induced inflammation in vivo Nanotoxicology July 1 2014 1 8 (Epub ahead of print)
68. B. Fadeel Clear and present danger? Engineered nanoparticles and the immune system Swiss Med. Wkly. 142 2012 w13609
69. G. Qu, S. Liu, S. Zhang, L. Wang, X. Wang, B. Sun, N. Yin, X. Gao, T. Xia, J.J. Chen, and G.B. Jiang Graphene oxide induces toll-like receptor 4 (TLR4)-dependent necrosis in macrophages ACS Nano 7 2013 5732 5745
70. C.Y. Tsai, S.L. Lu, C.W. Hu, C.S. Yeh, G.B. Lee, and H.Y. Lei Size-dependent attenuation of TLR9 signaling by gold nanoparticles in macrophages J. Immunol. 188 2012 68 76
71. N.G. Bastús, E. Sánchez-Tilló, S. Pujals, C. Farrera, M.J. Kogan, E. Giralt, A. Celada, J. Lloberas, and V. Puntes Peptides conjugated to gold nanoparticles induce macrophage activation Mol. Immunol. 46 2009 743 748
72. R. Roy, D. Kumar, A. Sharma, P. Gupta, B.P. Chaudhari, A. Tripathi, M. Das, and P.D. Dwivedi ZnO nanoparticles induced adjuvant effect via toll-like receptors and Src signaling in Balb/c mice Toxicol. Lett. 230 2014 421 433
73. M. Turabekova, B. Rasulev, M. Theodore, J. Jackman, D. Leszczynska, and J. Leszczynski Immunotoxicity of nanoparticles: a computational study suggests that CNTs and C60 fullerenes might be recognized as pathogens by Toll-like receptors Nanoscale 6 2014 3488 3495
74. E. Oliveira, M. Casado, M. Faria, A.M. Soares, J.M. Navas, C. Barata, and B. Piña Transcriptomic response of zebrafish embryos to polyaminoamine (PAMAM) dendrimers Nanotoxicology 8 Suppl. 1 2014 92 99
75. J. Lee, J.W. Sohn, Y. Zhang, K.W. Leong, D. Pisetsky, and B.A. Sullenger Nucleic acid-binding polymers as anti-inflammatory agents Proc. Natl. Acad. Sci. U.S.A. 108 2011 14055 14060
76. J. Banchereau, and R.M. Steinman Dendritic cells and the control of immunity Nature 392 1998 245 252
77. G. Laverny, A. Casset, A. Purohit, E. Schaeffer, C. Spiegelhalter, F. de Blay, and F. Pons Immunomodulatory properties of multi-walled carbon nanotubes in peripheral blood mononuclear cells from healthy subjects and allergic patients Toxicol. Lett. 217 2013 91 101
78. A.V. Tkach, G.V. Shurin, M.R. Shurin, E.R. Kisin, A.R. Murray, S.H. Young, A. Star, B. Fadeel, V.E. Kagan, and A.A. Shvedova Direct effects of carbon nanotubes on dendritic cells induce immune suppression upon pulmonary exposure ACS Nano 5 2011 5755 5762
79. A.V. Tkach, N. Yanamala, S. Stanley, M.R. Shurin, G.V. Shurin, E.R. Kisin, A.R. Murray, S. Pareso, T. Khaliullin, G.P. Kotchey, V. Castranova, S. Mathur, B. Fadeel, A. Star, V.E. Kagan, and A.A. Shvedova Graphene oxide, but not fullerenes, targets immunoproteasomes and suppresses antigen presentation by dendritic cells Small 9 2013 1686 1690
80. X. Zhi, H. Fang, C. Bao, G. Shen, J. Zhang, K. Wang, S. Guo, T. Wan, and D. Cui The immunotoxicity of graphene oxides and the effect of PVP-coating Biomaterials 34 2013 5254 5261
81. B.X. Chen, S.R. Wilson, M. Das, D.J. Coughlin, and B.F. Erlanger Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics Proc. Natl. Acad. Sci. U.S.A. 95 1998 10809 10813
82. M.A. Dobrovolskaia, and S.E. McNeil Immunological properties of engineered nanomaterials Nat. Nanotechnol. 2 2007 469 478
83. L.A. Mitchell, F.T. Lauer, S.W. Burchiel, and J.D. McDonald Mechanisms for how inhaled multiwalled carbon nanotubes suppress systemic immune function in mice Nat. Nanotechnol. 4 2009 451 456
84. A. Singh, H. Nie, B. Ghosn, H. Qin, L.W. Kwak, and K. Roy Efficient modulation of T-cell response by dual-mode, single-carrier delivery of cytokine-targeted siRNA and DNA vaccine to antigen-presenting cells Mol. Ther. 16 2008 2011 2021
85. S.U. Frick, N. Bacher, G. Baier, V. Mailänder, K. Landfester, and K. Steinbrink Functionalized polystyrene nanoparticles trigger human dendritic cell maturation resulting in enhanced CD4+ T cell activation Macromol. Biosci. 12 2012 1637 1647
86. S. Fallarini, T. Paoletti, C.O. Battaglini, P. Ronchi, L. Lay, R. Bonomi, S. Jha, F. Mancin, P. Scrimin, and G. Lombardi Factors affecting T cell responses induced by fully synthetic glyco-gold-nanoparticles Nanoscale 5 2013 390 400
87. B.C. Schanen, A.S. Karakoti, S. Seal, D.R. Drake, W.L. Warren, and W.T. Self Exposure to titanium dioxide nanomaterials provokes inflammation of an in vitro human immune construct ACS Nano 3 2009 2523 2532
88. P. Serafini Myeloid derived suppressor cells in physiological and pathological conditions: the good, the bad, and the ugly Immunol. Res. 57 2013 172 184
89. A.A. Shvedova, A.V. Tkach, E.R. Kisin, T. Khaliullin, S. Stanley, D.W. Gutkin, A. Star, Y. Chen, G.V. Shurin, V.E. Kagan, and M.R. Shurin Carbon nanotubes enhance metastatic growth of lung carcinoma via up-regulation of myeloid-derived suppressor cells Small 9 2013 1691 1695
90. M. Zhu, X. Tian, X. Song, Y. Li, Y. Tian, Y. Zhao, and G. Nie Nanoparticle-induced exosomes target antigen-presenting cells to initiate Th1-type immune activation Small 8 2012 2841 2848
91. J.J. Moon, B. Huang, and D.J. Irvine Engineering nano- and microparticles to tune immunity Adv. Mater. 24 2012 3724 3746
92. J.J. Moon, H. Suh, A. Bershteyn, M.T. Stephan, H. Liu, B. Huang, M. Sohail, S. Luo, S.H. Um, H. Khant, J.T. Goodwin, J. Ramos, W. Chiu, and D.J. Irvine Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses Nat. Mater. 10 2011 243 251
93. E. De Gregorio, E. Tritto, and R. Rappuoli Alum adjuvanticity: unraveling a century old mystery Eur. J. Immunol. 38 2008 2068 2071
94. S.T. Reddy, A.J. van der Vlies, E. Simeoni, V. Angeli, G.J. Randolph, C.P. O'Neil, L.K. Lee, M.A. Swartz, and J.A. Hubbell Exploiting lymphatic transport and complement activation in nanoparticle vaccines Nat. Biotechnol. 25 2007 1159 1164
95. S.P. Kasturi, I. Skountzou, R.A. Albrecht, D. Koutsonanos, T. Hua, H.I. Nakaya, R. Ravindran, S. Stewart, M. Alam, M. Kwissa, F. Villinger, N. Murthy, J. Steel, J. Jacob, R.J. Hogan, A. García-Sastre, R. Compans, and B. Pulendran Programming the magnitude and persistence of antibody responses with innate immunity Nature 470 2011 543 547
96. C.M. Hu, R.H. Fang, B.T. Luk, and L. Zhang Nanoparticle-detained toxins for safe and effective vaccination Nat. Nanotechnol. 8 2013 933 938
97. H. Dumortier When carbon nanotubes encounter the immune system: desirable and undesirable effects Adv. Drug Deliv. Rev. 65 2013 2120 2126
98. C.H. Villa, T. Dao, I. Ahearn, N. Fehrenbacher, E. Casey, D.A. Rey, T. Korontsvit, V. Zakhaleva, C.A. Batt, M.R. Philips, and D.A. Scheinberg Single-walled carbon nanotubes deliver peptide antigen into dendritic cells and enhance IgG responses to tumor-associated antigens ACS Nano 5 2011 5300 5311
99. C. Sacchetti, N. Rapini, A. Magrini, E. Cirelli, S. Bellucci, M. Mattei, N. Rosato, N. Bottini, and M. Bottini In vivo targeting of intratumor regulatory T cells using PEG-modified single-walled carbon nanotubes Bioconjug. Chem. 24 2013 852 858
100. K. Bhattacharya, C. Sacchetti, R. El-Sayed, A. Fornara, G.P. Kotchey, J.A. Gaugler, A. Star, M. Bottini, and B. Fadeel Enzymatic 'stripping' and degradation of PEGylated carbon nanotubes Nanoscale 6 2014 14686 14690
101. K. Bhattacharya, F.T. Andón, R. El-Sayed, and B. Fadeel Mechanisms of carbon nanotube-induced toxicity: focus on pulmonary inflammation Adv. Drug Deliv. Rev. 65 2013 2087 2097
102. F.T. Andón, and B. Fadeel Nanotoxicology: towards safety-by-design M.J. Alonso, M. Garcia-Fuentes, Nano-Oncologicals: New Targeting and Delivery Approaches 2014 Springer 391 424
103. H. Zhou, Q. Mu, N. Gao, A. Liu, Y. Xing, S. Gao, Q. Zhang, G. Qu, Y. Chen, G. Liu, B. Zhang, and B. Yan A nano-combinatorial library strategy for the discovery of nanotubes with reduced protein-binding, cytotoxicity, and immune response Nano Lett. 8 2008 859 865
104. C.L. Hardy, J.S. Lemasurier, R. Mohamud, J. Yao, S.D. Xiang, J.M. Rolland, R.E. O'Hehir, and M. Plebanski Differential uptake of nanoparticles and microparticles by pulmonary APC subsets induces discrete immunological imprints J. Immunol. 191 2013 5278 5290
105. B. Sun, Z. Ji, Y.P. Liao, M. Wang, X. Wang, J. Dong, C.H. Chang, R. Li, H. Zhang, A.E. Nel, and T. Xia Engineering an effective immune adjuvant by designed control of shape and crystallinity of aluminum oxyhydroxide nanoparticles ACS Nano 7 2013 10834 10849